If the off-label use of GLP-1s for type 1 diabetes becomes so prevalent as to be impossible to ignore, the FDA might mandate the companies to go and do these studies, says Garg
These symptoms usually occur during the first few weeks of treatment and may decrease
Better for individuals with significant weight loss goals, as studies show the injection leads to greater weight loss compared to the oral version
4): GLP-1 products have become the dominant drivers of total revenue for both Novo Nordisk and Eli Lilly
This section reviews alterations in muscle mass, muscle quality, and their underlying mechanisms during GLP-1 RA therapy, as illustrated in Fig
If the cold packs are hot and the vial feels warm, do not use it and contact the provider or pharmacy for a replacement